Key Quantitative Figures

Standalone Financial Results (Amount in INR crores):

  • Revenue from operations: ₹725.73 (Q1 FY26) vs ₹613.04 (Q1 FY25)
  • Other income: ₹39.03 (Q1 FY26) vs ₹38.43 (Q1 FY25)
  • Total income: ₹764.76 (Q1 FY26) vs ₹651.47 (Q1 FY25)
  • Profit before exceptional items and tax: ₹120.68 (Q1 FY26) vs ₹112.42 (Q1 FY25)
  • Exceptional items: ₹(109.79) (Q1 FY26) related to merger costs
  • Profit before tax: ₹10.89 (Q1 FY26) vs ₹108.03 (Q1 FY25)
  • Tax expense: ₹25.19 (Q1 FY26) vs ₹27.44 (Q1 FY25)
  • Net profit/(loss): ₹(14.30) loss (Q1 FY26) vs ₹80.59 profit (Q1 FY25)
  • Earnings per share (Basic): ₹(0.28) (Q1 FY26) vs ₹1.58 (Q1 FY25)
  • Paid-up equity share capital: ₹518.13 (face value ₹10 each)

Consolidated Financial Results (Amount in INR crores):

  • Revenue from operations: ₹1,310.68 (Q1 FY26) vs ₹1,077.87 (Q1 FY25)
  • Other income: ₹37.03 (Q1 FY26) vs ₹33.18 (Q1 FY25)
  • Total income: ₹1,347.71 (Q1 FY26) vs ₹1,111.05 (Q1 FY25)
  • Profit before share of loss, exceptional items and tax: ₹200.85 (Q1 FY26) vs ₹146.55 (Q1 FY25)
  • Share of loss of equity accounted investees: ₹(8.39) (Q1 FY26) vs ₹(5.72) (Q1 FY25)
  • Exceptional items: ₹(114.38) (Q1 FY26) related to merger costs
  • Profit before tax: ₹78.08 (Q1 FY26) vs ₹136.44 (Q1 FY25)
  • Tax expense: ₹48.80 (Q1 FY26) vs ₹42.88 (Q1 FY25)
  • Net profit: ₹29.28 (Q1 FY26) vs ₹93.56 (Q1 FY25)
  • Earnings per share (Basic): ₹0.31 (Q1 FY26) vs ₹1.67 (Q1 FY25)
  • Profit attributable to owners of the Company: ₹16.06 (Q1 FY26)
  • Profit attributable to non-controlling interests: ₹13.22 (Q1 FY26)

Dates of Action

  • Board meeting: 5 August 2026 (11:30 AM to 04:40 PM IST)
  • Quarter end: 30 June 2026
  • NCLT scheme sanction: 19 June 2026
  • INC-28 filing: 26 June 2026
  • Merger effective date: 1 July 2026
  • Additional investment in Aster DM-Super Specialty Hospital: 18 June 2026
  • Additional investment in Alfaone Medicals: 29 June 2026
  • CCPS allotment in ADMPL: 16 June 2026
  • CCPS allotment in Sarjapur Entity: 23 June 2026

Parties Involved

  • Transferor company: Quality Care India Limited (QCIL)
  • Regulator: National Company Law Tribunal (NCLT)
  • Auditors: Deloitte Haskins & Sells
  • Subsidiaries: 16 subsidiaries including Malabar Institute of Medical Sciences Limited, Aster DM Multispecialty Hospital Private Limited, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited
  • Associates: 4 associates including Alfaone Medicals Private Limited
  • ESOP Trust: DM Healthcare Employees Welfare Trust

Purpose or Rationale

The results disclosure is a regulatory requirement under SEBI Listing Regulations. The exceptional items of ₹109.79 crores (standalone) and ₹114.38 crores (consolidated) represent professional fees and other costs relating to the merger with Quality Care India Limited.

Financial Impact

  • Standalone: Net loss of ₹14.30 crores for Q1 FY26 primarily due to merger-related exceptional costs of ₹109.79 crores
  • Consolidated: Net profit of ₹29.28 crores for Q1 FY26 despite merger-related exceptional costs of ₹114.38 crores
  • Investment impact: Additional investments totaling ₹101.49 crores made during the quarter

Capital Structure Impact

  • Shareholding change: Company increased stake in Malabar Institute of Medical Sciences Limited from 79.75% to 81.29% through acquisition of 1.54% stake for ₹31.40 crores
  • Equity infusion: Subsidiaries ADMPL and Sarjapur Entity raised ₹19.34 crores through CCPS allotments
  • Preference share investment: ₹25.00 crores invested in OCRPS of Alfaone Medicals Private Limited

Operational Highlights by Segment (Consolidated)

  • Hospitals & Clinics: Revenue ₹1,277.63 crores, segment result ₹238.92 crores
  • Labs: Revenue ₹41.46 crores, segment result ₹2.92 crores
  • Wholesale Pharmacies: Revenue ₹30.43 crores, segment result ₹0.52 crores
  • Others: Revenue ₹1.56 crores, segment result ₹(0.61) crores

Additional Information

  • The financial results include interim financial information of 16 subsidiaries and ESOP trust not reviewed by their auditors
  • ESOP trust contributed revenue of ₹0.56 crores and net profit of ₹0.42 crores (standalone)
  • The figures for quarter ended 31 March 2026 are balancing figures between audited annual figures and unaudited nine-month figures
  • The company changed its name from "Aster DM Healthcare Limited" to "Aster DM Quality Care Limited" effective 1 July 2026 following the merger